B. M. Longenecker

D. Miles, M. Reddish, R. Rubens, 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment

B. Longenecker, C. Madsen, S. Gendler, 2001, Glycoconjugate Journal.

Immunogenicity and antitumor activity of a liposomal MUC1 peptide‐based vaccine

M. Reddish, B. Longenecker, G. Zimmermann, 1998, International journal of cancer.

Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69+ lymphocytes correlate with effects of Theratope® sialyl-Tn-KLH cancer vaccine in active specific immunotherapy

S. Poppema, M. Reddish, A. Berg, 1996, Cancer Immunology, Immunotherapy.

Immune Responses of Mice and Human Breast Cancer Patients following Immunization with Synthetic Sialyl‐Tn Conjugated to KLH Plus Detox Adjuvant

M. Reddish, B. M. Longenecker, R. Koganty, 1993, Annals of the New York Academy of Sciences.

Association of MUC-1 and SPGL-1 with low-density microdomain in T-lymphocytes: a preliminary note.

K. Handa, S. Hakomori, B. Longenecker, 2001, Biochemical and biophysical research communications.

The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer.

L. Pilarski, M. Reddish, J. Hugh, 1996, Cancer research.

Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigen.

B. Longenecker, B. M. Longenecker, A. P. Campbell, 2008, The journal of peptide research : official journal of the American Peptide Society.

Characterization of gp39, a B-lymphocyte associated differentiation antigen which is also present on granulocytes and macrophages.

B. Longenecker, G. Antoun, B. M. Longenecker, 1988, Molecular immunology.

Anti‐MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide

M. Reddish, B. Longenecker, B. M. Longenecker, 1998, International journal of cancer.

Role of the major histocompatibility complex in resistance to Marek's disease: restriction of the growth of JMV-MD tumor cells in genetically resistant birds.

B. Longenecker, J. Gavora, J. Spencer, 1977, Advances in experimental medicine and biology.

Tumor cell surface a'#,B integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-1 1 O/VCAM-1

D. Taichman, A. Aruffo, B. Longenecker, 2003 .

Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccine.

B. Sandmaier, M. Reddish, B. Longenecker, 1999, Journal of immunotherapy.

The major histocompatibility complex of the chicken

B. Longenecker, B. M. Longenecker, F. Pazderka, 1975, Immunogenetics.

Specificity analysis of murine monoclonal antibodies reactive with Tn, sialylated Tn, T, and monosialylated (2-->6) T antigens.

B. Longenecker, K. Lloyd, S. Welt, 1996, Hybridoma.

Radioiodinated peanut lectin: Clinical use as a tumour-imaging agent and potential use in assessing renal-tubular function

B. Longenecker, B. M. Longenecker, E. Abdi, 1986, European Journal of Nuclear Medicine.

Monoclonal antibodies directed against a widespread oncofetal antigen: the alpha-fetoprotein receptor.

T. Tamaoki, T. Wegmann, B. M. Longenecker, 1993, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation.

B. Longenecker, M. Krantz, B. Agrawal, 1998, Cancer research.

Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).

B. Longenecker, B. M. Longenecker, P. Y. Fung, 1991, Cancer research.

Active Specific Immunotherapy of a Murine Mammary Adenocarcinoma Using a Synthetic Tumor-associated Glycoconjugate1

M. Madej, B. Longenecker, B. M. Longenecker, 2006 .

CD30 expression on human CD8+ T cells isolated from peripheral blood lymphocytes of normal donors.

M. Reddish, B. Longenecker, B. Agrawal, 1996, Journal of immunology.

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer.

J. Taylor‐Papadimitriou, D. Miles, M. Reddish, 1996, British Journal of Cancer.

Human tumor cell membrane glycoprotein associated with protein kinase activity

A. Shaw, B. Longenecker, J. Seehafer, 1984, International journal of cancer.

The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy.

B. Longenecker, S. Gendler, B M Longenecker, 1998, Molecular medicine today.

Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1.

M. Cybulsky, G. Rice, D. Taichman, 1991, Cell regulation.

Rapid induction of primary human CD4+ and CD8+ T cell responses against cancer-associated MUC1 peptide epitopes.

M. Reddish, B. Longenecker, M. Krantz, 1998, International immunology.

Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.

M. Reddish, B. Longenecker, M. Krantz, 1998, Bioconjugate chemistry.

Biochemical characterization of human carcinoma surface antigen associated with protein kinase activity

B. Longenecker, J. Seehafer, B. M. Longenecker, 1984, International journal of cancer.

GENETIC CONTROL OF GRAFT‐VERSUS‐HOST COMPETENCE

B. Longenecker, B. M. Longenecker, R. Ruth, 1972, Transplantation.

Antigenic heterogeneity of human colorectal cancer cell lines analyzed by a panel of monoclonal antibodies. I. Heterogeneous expression of Ia-like and HLA-like antigenic determinants.

M. Kieran, A. Shaw, J. Seehafer, 1982, Journal of the National Cancer Institute.

Further Evidence that the Human Differentiation Antigen p24 Possesses Activity Associated with Protein Kinase

B. Longenecker, G. Antoun, B. M. Longenecker, 1986 .

Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine.

M. Reddish, B. Longenecker, B. M. Longenecker, 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer.

T. Ishida, E. Moase, W. Qi, 2001, Biochimica et biophysica acta.

A low-level expression of human MUC1 mucin enhances lethality of murine tumor cells

B. Longenecker, G. Zimmermann, M. Krantz, 2000, Cancer Immunology, Immunotherapy.

Does pregnancy immunize against breast cancer?

M. Reddish, B. Longenecker, M. Krantz, 1995, Cancer research.

Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: Effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene

J. Taylor‐Papadimitriou, M. Reddish, E. Lalani, 2005, Cancer Immunology, Immunotherapy.

Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.

M. Reddish, B. Longenecker, B. M. Longenecker, 1994, Advances in experimental medicine and biology.

Analysis of human tumor associated Thomsen-Friedenreich antigen.

M. Suresh, B. Longenecker, B. M. Longenecker, 1990, Cancer research.

GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21.

H. Oettgen, B. Longenecker, S. Adluri, 1995, Cancer research.

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

M. Reddish, B. Longenecker, J. Nabholtz, 2005, Cancer Immunology, Immunotherapy.

Murine T-cell clones specific for chicken erythrocyte alloantigens.

T. Mosmann, M. Giedlin, B. Longenecker, 1986, Cellular immunology.

Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patients.

M. Reddish, B. Longenecker, B. M. Longenecker, 1997, Journal of immunotherapy.

Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers.

M. Suresh, B. Longenecker, B. M. Longenecker, 1987, Journal of the National Cancer Institute.

The anti-MUC1 monoclonal antibody BCP8 can be used to isolate and identify putative major histocompatibility complex class I associated amino acid sequences.

M. Reddish, B. Longenecker, B. Agrawal, 1998, Cancer research.

Tolerance and autoimmunity to erythroid differentiation (B-G) major histocompatibility complex alloantigens of the chicken

B. Longenecker, C. Havele, T. Wegmann, 1982, The Journal of experimental medicine.

Radiolabelled peanut lectin for the scintigraphic detection of cancer.

M. Suresh, B. M. Longenecker, A. Noujaim, 1984, Cancer letters.

Radioimmunodetection of murine mammary adenocarcinoma (TA3/Ha) lung and liver metastases with radioiodinated PNA

M. Suresh, B. Longenecker, B. M. Longenecker, 1985, International journal of cancer.

In vivo localization of radioiodinated peanut lectin in a murine TA3/Ha mammary carcinoma model

M. Suresh, B. Longenecker, B. M. Longenecker, 2004, European Journal of Nuclear Medicine.

Antibody-mediated cellular cytotoxicity against Raji cells ADCC(RAJI): Evaluation of false positives in the detection of circulating immune complexes by Raji-cell assay

B. Longenecker, M. Dasgupta, B. M. Longenecker, 1982, Journal of Clinical Immunology.

The graft-versus-host reaction to minor alloantigens.

B. Longenecker, B. M. Longenecker, F. Pazderka, 1973, Cellular immunology.

T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo

M. Suresh, B. M. Longenecker, A. Noujaim, 2004, Cancer Immunology, Immunotherapy.

Comparative radiolabeling and distribution of a tumour-directed monoclonal antibody.

B. Longenecker, B. M. Longenecker, A. Noujaim, 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Characterization and Selection Criteria of Monoclonal Antibodies for Tumor Imaging Studies

M. Suresh, B. Longenecker, B. M. Longenecker, 1988 .

MODIFICATION BY HERPESVIRUS OF HEREDITARY GVHR COMPETENCY

B. M. Longenecker, F. Pazderka, R. Ruth, 1975 .

Anti-T antibodies and peanut-agglutinin-binding glycoproteins in sera of patients with gastric cancer

Sang-Nae Cho, B. Longenecker, D. Nahm, 1999, Journal of Cancer Research and Clinical Oncology.

Comparison of the 40 kDa hematopoietic cell antigens bound by monoclonal antibodies IV.3, 41H.16 and KB61.

B. Longenecker, G. Antoun, B. M. Longenecker, 1989, Molecular immunology.

In ovo assay for Marek's disease virus and turkey herpesvirus

B. Longenecker, J. Gavora, B. M. Longenecker, 1975, Infection and immunity.

MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats.

J. Hugh, B. Longenecker, M. Krantz, 1998, Cancer research.